← Back to all trials
Completed
NCT05739110
HCC Staging Modified by Tumor Micronecrosis
Conditions: Hepatocellular Carcinoma
Sex: All
Ages: 18 Years – 80 Years
Enrollment: 1100
Sponsor: Zhejiang University
Location: China
Summary
Tumor micronecrosis is a pathological feature that reflects malignant biological behavior in hepatocellular carcinoma (HCC).
This study aimed to evaluate the prognostic significance of tumor micronecrosis based on the current BCLC and TNM staging systems, and futher improve the performance of the staging models by establishing modified new staging models including tumor micronecrosis.
Eligibility Criteria
Inclusion Criteria:primary and histologically confirmed HCCspatients who underwent curative liver resectionExclusion Criteria:simultaneous presence of other tumorspatients who had received preoperative antitumor therapiesno available surgical specimens for evaluating micronecrosis statusgross tumor necrosis and Nscore = 3
Source: ClinicalTrials.gov (NCT05739110). StuddyBuddy aggregates publicly available trial information.